Trilogy Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-8,363
| Closed | -$241K | – | 326 |
|
2023
Q4 | $241K | Sell |
8,363
-539
| -6% | -$15.5K | 0.01% | 234 |
|
2023
Q3 | $295K | Sell |
8,902
-1,216
| -12% | -$40.3K | 0.02% | 194 |
|
2023
Q2 | $378K | Buy |
10,118
+1,805
| +22% | +$67.5K | 0.02% | 194 |
|
2023
Q1 | $339K | Buy |
8,313
+1,806
| +28% | +$73.7K | 0.02% | 190 |
|
2022
Q4 | $333K | Buy |
6,507
+1,606
| +33% | +$82.3K | 0.02% | 186 |
|
2022
Q3 | $214K | Buy |
4,901
+736
| +18% | +$32.1K | 0.02% | 169 |
|
2022
Q2 | $218K | Buy |
+4,165
| New | +$218K | 0.02% | 150 |
|
2019
Q1 | – | Sell |
-17,235
| Closed | -$714K | – | 155 |
|
2018
Q4 | $714K | Sell |
17,235
-1,195
| -6% | -$49.5K | 0.1% | 72 |
|
2018
Q3 | $771K | Sell |
18,430
-1,928
| -9% | -$80.7K | 0.1% | 72 |
|
2018
Q2 | $701K | Sell |
20,358
-33
| -0.2% | -$1.14K | 0.09% | 63 |
|
2018
Q1 | $687K | Buy |
+20,391
| New | +$687K | 0.1% | 59 |
|